1. Home
  2. WAFDP vs CGEN Comparison

WAFDP vs CGEN Comparison

Compare WAFDP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAFDP
  • CGEN
  • Stock Information
  • Founded
  • WAFDP N/A
  • CGEN 1993
  • Country
  • WAFDP United States
  • CGEN Israel
  • Employees
  • WAFDP 2208
  • CGEN N/A
  • Industry
  • WAFDP Major Banks
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WAFDP Finance
  • CGEN Health Care
  • Exchange
  • WAFDP Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • WAFDP N/A
  • CGEN 167.4M
  • IPO Year
  • WAFDP N/A
  • CGEN 2000
  • Fundamental
  • Price
  • WAFDP $16.05
  • CGEN $1.59
  • Analyst Decision
  • WAFDP
  • CGEN
  • Analyst Count
  • WAFDP 0
  • CGEN 0
  • Target Price
  • WAFDP N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • WAFDP N/A
  • CGEN 155.0K
  • Earning Date
  • WAFDP N/A
  • CGEN 08-05-2025
  • Dividend Yield
  • WAFDP N/A
  • CGEN N/A
  • EPS Growth
  • WAFDP N/A
  • CGEN N/A
  • EPS
  • WAFDP N/A
  • CGEN N/A
  • Revenue
  • WAFDP N/A
  • CGEN $27,589,000.00
  • Revenue This Year
  • WAFDP N/A
  • CGEN N/A
  • Revenue Next Year
  • WAFDP N/A
  • CGEN $173.80
  • P/E Ratio
  • WAFDP N/A
  • CGEN N/A
  • Revenue Growth
  • WAFDP N/A
  • CGEN N/A
  • 52 Week Low
  • WAFDP N/A
  • CGEN $1.13
  • 52 Week High
  • WAFDP N/A
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • WAFDP 57.24
  • CGEN 44.35
  • Support Level
  • WAFDP $15.55
  • CGEN $1.66
  • Resistance Level
  • WAFDP $16.25
  • CGEN $1.74
  • Average True Range (ATR)
  • WAFDP 0.20
  • CGEN 0.10
  • MACD
  • WAFDP 0.06
  • CGEN -0.02
  • Stochastic Oscillator
  • WAFDP 77.78
  • CGEN 8.00

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: